Pentamethoxymorin (MRS923) is a selective b reast cancer resistance protein (BCRP/ABCG2) inhibitor . Pentamethoxymorin shows selectivity for BCRP over P-gp and MRP1. Pentamethoxymorin inhibits MDCK BCRP cells with IC 50 vaues of 5.98 μM and 5.94 μM in Hoechst 33342 ( HY-15559 ) assay and Pheophorbide A ( HY-125665 ) assay, respectively. Pentamethoxymorin can be used for the study of ccancer.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > BCRP
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.